Yifang Biotechnology (688382.SH) terminates the implementation of the 2025 restricted stock incentive plan.
Yifang Biotechnology (688382.SH) announced that, due to various influences such as the current macro environment, capital markets, and price fluctuations in the secondary market, it will be difficult to achieve the expected incentive goals and effects if the 2025 restricted stock incentive plan continues to be implemented.
Yifang Bio (688382.SH) announced that, due to various influences such as the current macro environment, capital market, and fluctuations in the secondary market prices, it would be difficult to achieve the expected incentive goals and effects if the 2025 Restricted Stock Incentive Plan continues to be implemented. After careful consideration by the company's board of directors, the company plans to terminate the implementation of the "Yifang Bio Technology (Shanghai) Co., Ltd. 2025 Restricted Stock Incentive Plan (draft)", along with the related document "Yifang Bio Technology (Shanghai) Co., Ltd. 2025 Restricted Stock Incentive Plan Implementation Assessment and Management Measures". In the future, the company will timely launch a more suitable incentive plan that aligns with the company's development strategy and business objectives and effectively combines the medium and long-term interests of shareholders, the company, and employees.
Related Articles

Haitong UT (01905) nominates Dong Boyang and Ao Qishun as non-executive directors.

TCL ELECTRONICS (01070) establishes an Environment, Social, and Governance Committee.

With AERO TECH (00232) announcing annual performance, shareholders' attributable profit is HK$94.066 million, a year-on-year growth of 67.95%.
Haitong UT (01905) nominates Dong Boyang and Ao Qishun as non-executive directors.

TCL ELECTRONICS (01070) establishes an Environment, Social, and Governance Committee.

With AERO TECH (00232) announcing annual performance, shareholders' attributable profit is HK$94.066 million, a year-on-year growth of 67.95%.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


